1.	Phase I Study of LMB-9 Immunotoxin in Patients With Advanced Solid Tumors That Express Lewis Y Antigen (Summary Last Modified 07/2002) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-98-C-0078A, NCI-MB-400, NCI-T98-0005, T98-0005, NCT00019435
2.	LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000067885, MSGCC-9981, MSGCC-IRB-0200123, NCI-511, 511, NCT00005858
3.	Phase I Study of LMB-9 Immunotoxin in Patients With Advanced Adenocarcinoma of the Colon, Rectum, Pancreas, Esophagus, or Stomach With Overexpression of the Lewis-Y Antigen. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UFMC-431, UFMC-IND-7697, UFMC-NSC-691236, NCI-431, EU-20120, NCT00010270, 431